Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mazurier

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
International Journal of Laboratory Hematology|January 16, 2009
Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferationA Nasef, Y Z Zhang, C Mazurier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
von Willebrand disease: laboratory aspects of diagnosis and treatmentE J Favaloro, D Lillicrap, M A Lazzari, et al.
Blood|February 13, 2001
The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factorA N Ribba, L Hilbert, J M Lavergne, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWDJ Eikenboom, V Van Marion, H Putter, et al.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)U Budde, R Schneppenheim, J Eikenboom, et al.
Journal of Thrombosis and Haemostasis : JTH|August 8, 2006
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand FactorJ E Sadler, U Budde, J C J Eikenboom, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD studyJ Eikenboom, L Hilbert, A S Ribba, et al.
Blood|September 15, 1995
Factor VIII gene inversions in severe hemophilia A: results of an international consortium studyS E Antonarakis, J P Rossiter, M Young, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
International Journal of Laboratory Hematology|January 16, 2009
Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferationA Nasef, Y Z Zhang, C Mazurier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
von Willebrand disease: laboratory aspects of diagnosis and treatmentE J Favaloro, D Lillicrap, M A Lazzari, et al.
Blood|February 13, 2001
The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factorA N Ribba, L Hilbert, J M Lavergne, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWDJ Eikenboom, V Van Marion, H Putter, et al.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)U Budde, R Schneppenheim, J Eikenboom, et al.
Journal of Thrombosis and Haemostasis : JTH|August 8, 2006
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand FactorJ E Sadler, U Budde, J C J Eikenboom, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD studyJ Eikenboom, L Hilbert, A S Ribba, et al.
Blood|September 15, 1995
Factor VIII gene inversions in severe hemophilia A: results of an international consortium studyS E Antonarakis, J P Rossiter, M Young, et al.
Pageof 13